1030 related articles for article (PubMed ID: 19298183)
1. Biological and chemical approaches to diseases of proteostasis deficiency.
Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational Diseases.
Kelly JW
Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31088828
[TBL] [Abstract][Full Text] [Related]
3. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
4. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL; Kelly JW
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
[TBL] [Abstract][Full Text] [Related]
5. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperones in protein folding and proteostasis.
Hartl FU; Bracher A; Hayer-Hartl M
Nature; 2011 Jul; 475(7356):324-32. PubMed ID: 21776078
[TBL] [Abstract][Full Text] [Related]
7. The proteostasis boundary in misfolding diseases of membrane traffic.
Hutt DM; Powers ET; Balch WE
FEBS Lett; 2009 Aug; 583(16):2639-46. PubMed ID: 19708088
[TBL] [Abstract][Full Text] [Related]
8. The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.
Brandvold KR; Morimoto RI
J Mol Biol; 2015 Sep; 427(18):2931-47. PubMed ID: 26003923
[TBL] [Abstract][Full Text] [Related]
9. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
11. Protein homeostasis as a therapeutic target for diseases of protein conformation.
Calamini B; Morimoto RI
Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
Karatas E; Bouchecareilh M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
[TBL] [Abstract][Full Text] [Related]
13. Protein Misfolding Diseases and Therapeutic Approaches.
Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
[TBL] [Abstract][Full Text] [Related]
14. Pathways of cellular proteostasis in aging and disease.
Klaips CL; Jayaraj GG; Hartl FU
J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
[TBL] [Abstract][Full Text] [Related]
15. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
16. Carrying Excess Baggage Can Slowdown Life: Protein Clearance Machineries That Go Awry During Aging and the Relevance of Maintaining Them.
Sarkar A; Nazir A
Mol Neurobiol; 2022 Feb; 59(2):821-840. PubMed ID: 34792731
[TBL] [Abstract][Full Text] [Related]
17. Protein folding, misfolding and quality control: the role of molecular chaperones.
Papsdorf K; Richter K
Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
[TBL] [Abstract][Full Text] [Related]
18. Chemical and biological approaches synergize to ameliorate protein-folding diseases.
Mu TW; Ong DS; Wang YJ; Balch WE; Yates JR; Segatori L; Kelly JW
Cell; 2008 Sep; 134(5):769-81. PubMed ID: 18775310
[TBL] [Abstract][Full Text] [Related]
19. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
Ong DS; Kelly JW
Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.
Strub MD; McCray PB
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32414011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
